Language : English
Zuo Xiao Cong

Journal Publications

Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers

Impact Factor:5.6

DOI number:10.3389/fphar.2019.01231

Journal:FRONTIERS IN PHARMACOLOGY

Co-author:Zou, C (Zou, Chan), Huang, J (Huang, Jie), Hua, Y (Hua, Ye), S (Yang, Shuang), XY (Yang, Xiaoyan), Guo, C (Guo, Can), Tan, HY (Tan, Hongyi), Chen, J (Chen, Jun), Chu, ZX (Chu, Zhaoxing), Pei, Q (Pei, Qi), Yang, GP (Yang, Guoping)

Translation or Not:no